The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2015

Filed:

Aug. 31, 2010
Applicants:

Ekkehard Mössner, Kreuzlingen, CH;

Thomas U. Hofer, Zürich, CH;

Ralf Jörg Hosse, Bonstetten, CH;

Pablo Umaña, Wädenswil, CH;

Inventors:

Ekkehard Mössner, Kreuzlingen, CH;

Thomas U. Hofer, Zürich, CH;

Ralf Jörg Hosse, Bonstetten, CH;

Pablo Umaña, Wädenswil, CH;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C07K 16/46 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3007 (2013.01); C07K 2317/24 (2013.01); C07K 2317/55 (2013.01);
Abstract

The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies or variants thereof specific for cell surface or membrane bound human CEA. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.


Find Patent Forward Citations

Loading…